Cargando…
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
The coronavirus 2019 (COVID-19) pandemic is expected to linger. Decisions regarding initiation or continuation of disease-modifying therapy for multiple sclerosis have to consider the potential relevance to the pandemic. Understanding the mechanism of action and the possible idiosyncratic effects of...
Autores principales: | Zheng, Crystal, Kar, Indrani, Chen, Claire Kaori, Sau, Crystal, Woodson, Sophia, Serra, Alessandro, Abboud, Hesham |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417850/ https://www.ncbi.nlm.nih.gov/pubmed/32780300 http://dx.doi.org/10.1007/s40263-020-00756-y |
Ejemplares similares
-
Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic
por: Abboud, Hesham, et al.
Publicado: (2020) -
Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
por: Edan, Gilles, et al.
Publicado: (2013) -
Myxosporean parasites in Australian frogs: Importance, implications and future directions
por: Hartigan, Ashlie, et al.
Publicado: (2013) -
Escalation Versus Induction/High-Efficacy Treatment Strategies for Relapsing Multiple Sclerosis: Which is Best for Patients?
por: Edan, Gilles, et al.
Publicado: (2023) -
Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain–Barré Syndrome and Narcolepsy
por: Stowe, Julia, et al.
Publicado: (2019)